5.80
price down icon2.68%   -0.16
after-market Dopo l'orario di chiusura: 6.00 0.20 +3.45%
loading
Precedente Chiudi:
$5.96
Aprire:
$5.97
Volume 24 ore:
167.43K
Relative Volume:
0.84
Capitalizzazione di mercato:
$50.29M
Reddito:
$137.27M
Utile/perdita netta:
$-123.57M
Rapporto P/E:
-0.5265
EPS:
-11.016
Flusso di cassa netto:
$-102.89M
1 W Prestazione:
-8.52%
1M Prestazione:
-11.31%
6M Prestazione:
-14.07%
1 anno Prestazione:
-60.93%
Intervallo 1D:
Value
$5.75
$6.10
Intervallo di 1 settimana:
Value
$5.75
$6.60
Portata 52W:
Value
$3.51
$15.30

Karyopharm Therapeutics Inc Stock (KPTI) Company Profile

Name
Nome
Karyopharm Therapeutics Inc
Name
Telefono
617-658-0600
Name
Indirizzo
85 WELLS AVENUE, NEWTON, MA
Name
Dipendente
279
Name
Cinguettio
@Karyopharm
Name
Prossima data di guadagno
2024-11-05
Name
Ultimi documenti SEC
Name
KPTI's Discussions on Twitter

Confronta KPTI con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
KPTI
Karyopharm Therapeutics Inc
5.80 94.92M 137.27M -123.57M -102.89M -11.02
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
425.57 107.66B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
651.80 68.74B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
456.04 58.93B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
818.50 50.51B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
189.60 41.29B 447.02M -1.18B -868.57M -6.1812

Karyopharm Therapeutics Inc Stock (KPTI) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-10-13 Aggiornamento H.C. Wainwright Neutral → Buy
2025-07-16 Downgrade H.C. Wainwright Buy → Neutral
2025-07-11 Ripresa H.C. Wainwright Buy
2023-01-19 Iniziato Piper Sandler Overweight
2022-11-04 Aggiornamento RBC Capital Mkts Sector Perform → Outperform
2022-02-09 Aggiornamento JP Morgan Underweight → Neutral
2021-11-19 Ripresa Morgan Stanley Equal-Weight
2021-08-06 Downgrade JP Morgan Overweight → Neutral
2021-08-06 Downgrade RBC Capital Mkts Outperform → Sector Perform
2021-08-06 Downgrade SVB Leerink Outperform → Mkt Perform
2020-07-02 Iniziato Morgan Stanley Overweight
2020-03-04 Iniziato Barclays Overweight
2020-01-17 Downgrade Wedbush Outperform → Neutral
2019-07-23 Aggiornamento JP Morgan Neutral → Overweight
2019-07-05 Reiterato H.C. Wainwright Buy
2019-07-05 Reiterato Robert W. Baird Outperform
2019-03-01 Downgrade JP Morgan Overweight → Neutral
2019-02-28 Reiterato BofA/Merrill Underperform
2019-02-27 Downgrade BofA/Merrill Neutral → Underperform
2019-01-03 Aggiornamento BofA/Merrill Underperform → Neutral
2018-12-03 Iniziato B. Riley FBR Buy
2018-11-09 Aggiornamento Wedbush Neutral → Outperform
2018-05-24 Downgrade Wedbush Outperform → Neutral
2018-04-02 Ripresa Leerink Partners Outperform
2017-11-15 Ripresa H.C. Wainwright Buy
2017-09-15 Iniziato RBC Capital Mkts Outperform
2016-09-08 Reiterato H.C. Wainwright Buy
2016-08-30 Aggiornamento Jefferies Hold → Buy
2016-08-18 Iniziato H.C. Wainwright Buy
2016-06-28 Iniziato Robert W. Baird Outperform
Mostra tutto

Karyopharm Therapeutics Inc Borsa (KPTI) Ultime notizie

pulisher
Nov 02, 2025

Karyopharm Therapeutics Inc. stock trend outlook and recovery path2025 Trading Volume Trends & Real-Time Market Trend Scan - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Can Karyopharm Therapeutics Inc. stock continue upward trend2025 Market Sentiment & Daily Stock Trend Reports - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

How geopolitical tensions affect Karyopharm Therapeutics Inc. stockWeekly Trend Summary & AI Driven Price Predictions - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

What makes Karyopharm Therapeutics Inc. (25K0) stock appealing to growth investors2025 Technical Overview & Reliable Volume Spike Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Analyzing net buyer seller activity in Karyopharm Therapeutics Inc.July 2025 Closing Moves & Weekly Chart Analysis and Guides - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Is Karyopharm Therapeutics Inc. stock safe for conservative investorsPortfolio Profit Report & AI Based Buy/Sell Signal Reports - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Is Karyopharm Therapeutics Inc. stock vulnerable to regulatory risksWeekly Earnings Recap & Weekly Return Optimization Alerts - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

Karyopharm Therapeutics Inc expected to post a loss of $3.13 a shareEarnings Preview - TradingView

Oct 31, 2025
pulisher
Oct 31, 2025

Earnings To Watch: Karyopharm Therapeutics Inc (KPTI) Reports Q3 2025 Result - Yahoo Finance

Oct 31, 2025
pulisher
Oct 31, 2025

Technical signs of recovery in Karyopharm Therapeutics Inc.2025 Technical Overview & Safe Entry Trade Signal Reports - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Is Karyopharm Therapeutics Inc. (25K0) stock a top hedge fund pickJuly 2025 Levels & Community Trade Idea Sharing Platform - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Regression analysis insights on Karyopharm Therapeutics Inc. performance2025 Year in Review & Free High Accuracy Swing Entry Alerts - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Published on: 2025-10-31 05:27:00 - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Using Ichimoku Cloud for Karyopharm Therapeutics Inc. technicals2025 Big Picture & Reliable Intraday Trade Plans - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Can Karyopharm Therapeutics Inc. (25K0) stock sustain revenue momentumQuarterly Performance Summary & Daily Chart Pattern Signals - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Is Karyopharm Therapeutics Inc. (25K0) stock cheap vs fundamentals2025 Breakouts & Breakdowns & Fast Entry and Exit Trade Plans - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Will Karyopharm Therapeutics Inc. stock benefit from AI adoptionWeekly Trade Recap & Verified Swing Trading Watchlists - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

Karyopharm Therapeutics (KPTI) Price Target Decreased by 10.98% to 15.98 - MSN

Oct 30, 2025
pulisher
Oct 30, 2025

Karyopharm Therapeutics (NASDAQ:KPTI) Shares Pass Above 50-Day Moving AverageHere's What Happened - MarketBeat

Oct 30, 2025
pulisher
Oct 30, 2025

Is it time to cut losses on Karyopharm Therapeutics Inc.Trade Risk Summary & Low Drawdown Trading Strategies - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Is Karyopharm Therapeutics Inc. stock supported by strong fundamentals2025 Price Momentum & Fast Gain Stock Trading Tips - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Will Karyopharm Therapeutics Inc. outperform the market2025 Short Interest & Accurate Technical Buy Alerts - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

Will Karyopharm Therapeutics Inc. stock gain from strong economyWall Street Watch & Intraday High Probability Alerts - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Karyopharm Therapeutics (KPTI) Projected to Post Earnings on Tuesday - MarketBeat

Oct 29, 2025
pulisher
Oct 28, 2025

What dividend safety score for Karyopharm Therapeutics Inc. stock2025 Geopolitical Influence & Reliable Price Breakout Alerts - fcp.pa.gov.br

Oct 28, 2025
pulisher
Oct 28, 2025

Karyopharm Therapeutics Inc. (25K0.SG) stock price, news, quote and history - Yahoo! Finance UK

Oct 28, 2025
pulisher
Oct 28, 2025

Karyopharm Therapeutics Inc. (25K0.SG) latest stock news and headlines - Yahoo! Finance UK

Oct 28, 2025

Karyopharm Therapeutics Inc Azioni (KPTI) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$37.54
price up icon 1.62%
$93.48
price up icon 0.96%
$28.61
price down icon 0.21%
$103.91
price down icon 0.73%
biotechnology ONC
$310.48
price up icon 0.73%
$189.60
price down icon 2.38%
Capitalizzazione:     |  Volume (24 ore):